XML 37 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue $ 72,252,833 $ 62,846,832
Cost of goods sold 69,784,021 60,700,879
Gross profit 2,468,812 2,145,953 Close
Operating expenses:     Close
Distribution, selling, and administrative 1,398,747 1,290,928 Close
Depreciation 104,178 99,542 Close
Amortization 166,425 72,398 Close
Litigation and opioid-related (credit) expenses (78,917) 12,706 Close
Acquisition-related deal and integration expenses 21,063 20,996 Close
Restructuring and other expenses 34,441 16,240 CloseClose
Total Operating Expenses 1645937.0 1512810.0 0 0 0 Close
Operating income 822,875 633,143 Close
Other income, net (1,087) (6,328) CloseClose
Total Other Income Expenses 39477.0 39688.0 0.0 0 0 Close
Interest expense, net 40,564 46,016 CloseClose
Income before income taxes 783,398 593,455 Close
Income tax expense 180,390 117,285 Close
Net income 603,008 476,170 Close
Net (income) loss attributable to noncontrolling interests (1,508) 3,575
Net income attributable to Cencora, Inc. $ 601,500 $ 479,745
Earnings per share:    
Basic (usd per share) $ 3.01 $ 2.35
Diluted (usd per share) $ 2.98 $ 2.33
Weighted average common shares outstanding:    
Basic (shares) 200,081 204,032
Diluted (shares) 201,837 206,327
Cash dividends declared per share of common stock (usd per share) $ 0.510 $ 0.485